22.89
1.15%
0.26
Precedente Chiudi:
$22.63
Aprire:
$22.75
Volume 24 ore:
4,300
Relative Volume:
0.13
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.30%
1M Prestazione:
-6.99%
6M Prestazione:
+0.15%
1 anno Prestazione:
-2.14%
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
Nome
Ishares Genomics Immunology And Healthcare Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta IDNA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
IDNA
Ishares Genomics Immunology And Healthcare Etf
|
22.89 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
292.02 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
590.11 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
592.94 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
242.50 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
515.48 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf Borsa (IDNA) Ultime notizie
Future Health: Harnessing Innovations In Healthcare - Syfe
Thematic Portfolios Re-optimisation – Capturing Emerging Trends and Maximising Growth Potential - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
7 Best Biotech ETFs In Canada for December 2024 - Wealth Awesome
iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) Quotes, Forecast and News Summary - Benzinga
iShares Genomics Immunology and Healthcare ETF declares semi-annual distribution of $0.1114 - MSN
BlackRock® Canada Announces June Cash Distributions for the iShares® ETFs - Yahoo Finance
IDNA ETF: Healthcare Dashboard For February - Seeking Alpha
Top Thematic ETF Ideas for 2024: AI & More - Yahoo Canada Finance
Has Biotechnology Bottomed Out? - Master Investor
2024 Market Forecast: 3 Key Trends in the Healthcare Industry - InvestorPlace
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
IDNA: Continues To Underperform, But With Long-Term Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - U.S News & World Report Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - InvestorPlace
Noticeable performance for Healthcare and Biotech ETFs - Trackinsight
Biotech ETFs Slip After Novavax Cuts 2022 Guidance - ETF Trends
RBC iShares Opens the Market - Canada NewsWire
Biotech Shares Too Risky? Here's An ETF For Safely Avoiding The Volatility - Investing.com India
ETF Battles: ARKG Vs IDNA Vs GNOM - Yahoo Finance
Why ETFs may be the best way to bet on the future of biotech - The Globe and Mail
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
Go Beyond Trends: Healthcare Megatrends and IDNA - ETFdb.com
Genomics ETFs Surge on CRISPR's Gene Editing Progress - Zacks Investment Research
Why megatrend ETFs offer long-term growth potential - ETF Strategy
BlackRock dives deeper into thematic ETFs: Fund Scan - Financial Planning
iShares Lists Cybersecurity and Genomics ETFs - ETF Trends
BlackRock lists genomics and cyber security ETFs - ETF Stream
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
ARK Genomic Revolution ETF - ETFdb.com
Ishares Genomics Immunology And Healthcare Etf Azioni (IDNA) Dati Finanziari
Non sono disponibili dati finanziari per Ishares Genomics Immunology And Healthcare Etf (IDNA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):